Sep 5, 2018

Creoptix Sponsors Talk at Discovery on Target 2018

Don't miss Michael Hennig's talk!

See you in Boston!

Dr. Michael Hennig, CEO of leadXpro, will talk about the company’s experience with the Creoptix WAVEsystem when measuring ligand binding and kinetics to support drug design.

What? Biophysical Methods in Drug Discovery Dedicated to Membrane Protein Targets with Dr. Michael Hennig from leadXpro

When? On September 27th at 3:55 pm

Where? Room Back Bay B

Track? GPCR